REPUBLIC of the PHILIPPINES

City of Makati
UNIVERSITY OF MAKATI
COLLEGE OF ALLIED HEALTH STUDIES
MIDPOINT OF NURSING
J.P. Rizal Extension, West Rembo, Makati City 1215
Telephone No.: (+632) – 881 – 1571
_____________________________________________________________________
CENTER OF NURSING
DRUG STUDY
NAME OF STUDENT:___________________________________ YEAR/GROUP:__________ CONCEPT:_______________ AREA:________ DATE:__________
DRUG NAME MECHANISM OF INDICATION SIDE EFFECT CONTRAINDICATION NURSING CONSIDERATION
ACTION /ADVERSE
EFFECT
Generic name Blocks dopamine Monotherapy or CNS: Akathisia, Contraindicated in patients Monitor patient for tardive dyskinesia, which may occur
Risperidone and5-HT2receptors combination therapy somnolence, dystonia, hypersensitive to drug and after prolonged use.
in the brain. with lithium or headache, insomnia, in breast-feeding women.
Brand name valproate for 3-week agitation, anxiety, pain, Use cautiously in patients It may not appear until months or years later and may
Respirdal treatment of acute parkinsonism, with prolonged QT interval, disappear spontaneously or persist for life, despite
manic or mixed neuroleptic malignant CV disease, stopping drug.
episodes from syndrome, suicide cerebrovascular disease,
Classification bipolar disorder. attempt, dizziness, dehaydration, hypovolemia, Life-threatening hyperglycemia may occur in patients
Anti-psychotic 12-week parental fever, hallucination, history of seizures, or taking atypical antipsychotics.
therapy for mania, impaired conditions that could affect
schizophrenia. concentration. metabolism or Monitor patients with diabetes regularly. Periodically
hemodynamic responses. reevaluate
Dosage CV: tachycardia, chest Use cautiously in patients drug’s risks and benefits, especially during prolonged
Adults: Initial dosing pain, orthostatic exposed to extreme heat use.
is generally 2mg PO hypotension, peripheral Monitor patient for weight gain.
daily. edema, syncope,
hypertension
Adolescents ages
13 to17: Start
treatment with0.5
mg PO once daily,
given as a single
daily dose in the
morning or evening.

NAME OF PATIENT:__________________________________
CLINICAL IMPRESSION/DIAGNOSIS:_________________________________
AGE:__________________
PATIENT CHIEF COMPLAINT:____________________________